The leucyl-tRNA synthetase gene (leuS) of BaciUlus subtilis was cloned and sequenced. A mutation in the gene, kuSI, increases the transcription and expression of the ilv-leu operon, permitting monitoring of leuS alleles. The kuSI mutation was mapped to 2700 on the chromosome. Sequence analysis showed that the mutation is a single-base substitution, possibly in a monocistronic operon. The leader mRNA predicted by the sequence would contain a number of possible secondary structures and a T box, a sequence observed upstream of leader mRNA terminators of BaciUlus tRNA synthetases and the B. subtilis ilv-ku operon. The DNA of the B. subtilis leuS open reading frame is 48% identical to the leuS gene of Escherichia coli and is predicted to encode a polypeptide with 46% identity to the leucyl-tRNA synthetase of E. coli.
The critical process of accurate charging of tRNAs by aminoacyl-tRNA synthetases presents a unique opportunity to study protein-nucleotide interaction. All of the tRNA synthetases of Eschenichia coli have been cloned and sequenced (9) . Several tRNA synthetases have been crystallized, some bound to their substrates (3, 4, 25) . The enzymes have been divided into two types (4, 8, 27 ) based upon sequence and structural homologies. Type I enzymes include those for arginine, cysteine, glutamine, glutamic acid, isoleucine, leucine, methionine, tryptophan, tyrosine, and valine. These enzymes all contain several conserved amino acid sequences, including HIGH and KMSKS (part of the ATP-binding Rossman fold). Type II enzymes include those for alanine, asparagine, aspartic acid, glycine, histidine, lysine, phenylalanine, proline, serine, and threonine. These enzymes lack the HIGH and KMSKS motifs but share (to a degree) three other motifs (8) .
The E. coli leucyl-tRNA synthetase belongs to a subgroup of type I synthetases known as the XUX family (for the codons recognized by these enzymes). This group includes the leucine, isoleucine, valine, and methionine enzymes (27) . Sequence and structural homologies suggest that these enzymes evolved from a common ancestral enzyme, an early divergence from the other type I aminoacyl-tRNA synthetases.
We cloned the leuS gene as part of a study of mutations that result in increased expression of the ilv-leu operon of Bacillus subtilis. The ilv-leu operon contains, in order, the genes ilvB, ilvN, ilvC, leuA, leuC, leuB, and leuD. The operon is transcriptionally regulated by the amino acid leucine (11, 31, 32) . Strains carrying a transposon insertion in the ilvN gene (ilvN: :Tn917) cannot grow in the presence of high concentrations of leucine. This sensitivity is overcome by the addition of isoleucine and valine. Presumably, the decreased transcription of the operon caused by the addition of leucine, combined with the decreased activity of the IlvN-inactivated IlvBN enzyme (acetohydroxyacid synthase), causes the cells to starve for valine and isoleucine. The (31, 32) of ,B-galactosidase expression from an ilvN::lacZ fusion showed that leuS] increases transcription of the ilv-leu operon. (Note that the leuS gene was called ilvX in reference 31 .) The 3-galactosidase expression is high enough for ilvN::lacZ leuSI mutants to appear blue on complex media plus 5-bromo-4-chloro-3-indolyl-3-D-galactoside (XGal). ilvN::lacZ leuS+ strains are colorless.
MATERIALS AND METHODS
Bacterial strains, plasmids, bacteriophages. The bacterial strains, plasmids, and bacteriophages used in this study are described in Table 1 .
Media. Bacteria were grown on tryptose blood agar base (TBAB; Difco) solid medium or in Luria-Bertani (LB) broth (17) . M13 was propagated in 2YT medium (2) . Overlays contained LB and 0.75% agar. Additives for E. coli selections included 35 ,ug of ampicillin ml-'. Additives for B. subtilis selections included 1 ,ug of erythromycin ml-1 and 25 ,ug of lincomycin ml-' (Mlsr), 5 ,ug of chloramphenicol ml-' (Camr), or 20 jg of 4-azaleucine ml-' (Azlr). E. coli transfections with M13mpl9 and its clone-containing derivatives were plated with overlays onto defined minimal-glucose agar medium supplemented with 12 ,ug of thiamine ml-1, 40 jig of X-Gal ml-, and 4 jiM isopropyl-thiogalactoside.
DNA isolations. Plasmids were isolated on a small scale by the Holmes and Quigley boiling method (15) . Isolation of plasmids on a large scale and double-stranded bacteriophage M13 DNAs was as described previously (2) . DNAs from bacteriophage lambda and its derivatives were isolated by the method of Davis et al. (6) . Single-stranded M13 clone DNA was isolated as described previously (17) .
Bacterial transformations. Competent cells of E. coli were prepared by the method of Hanahan (12) . B. subtilis was transformed by the procedure of Yasbin et al. (34) .
Transposon tagging of leuS. As stated above, the leuSI allele can be monitored by plating an ilvN::lacZ transcriptional fusion-containing strain of B. subtilis on TBAB containing X-Gal. After incubation at 37°C for 24 h, leuS+ strains are colorless and leuSI strains are blue.
Transposon Tn917[60] is the chr::Tn917-lac::pTV21A2 construct described by Youngman (35) . The transposon Isolation and analysis of M13 subclones. Various fragments from pVH401, pVH402 or X-leuS were ligated to replicativeform DNA of M13mpl8 and M13mpl9 (19) (Fig. 1 ). Ligation mixtures were transfected into E. coli JM101. Then 5 ,u1 of M13 loading buffer (1% sodium dodecyl sulfate, 0.1% bromophenol blue, 50% glycerol, 250 mM EDTA) was added to 20 ,ul of a bacteriophage lysate prepared from colorless plaques. Dot blots of the mixtures were analyzed by hybridization to various radiolabeled DNA fragments. Hybridization was carried out as described previously (17) , except that two types of probes were used as needed. First, doublestranded DNA probes were used to identify the presence of particular cloned fragments. These probes were radiolabeled by using the Prime-A-Gene (Promega) labeling system. Second, sequencing reactions were used as single-stranded DNA probes to identify the orientation of inserts.
The EcoRI fragment present in M13mpl9-X-1euSL.A1 resisted cloning in the opposite orientation. The missing strand was sequenced by double-strand sequencing of the replicative form of M13mpl9-X-1euSL.A1. 
TCCGGTAGAGAGACGCCTAATGAAGCAGTGGATGCTGAAAATCAACGCTTATGCGGACAGGCTCCTTGAGGACTTGGAAGAGCTTGATTGGCCGGAAAGC I K D M Q R N W I G R S E G A H V H F A I D G H D D S F T V F T T D
1001 ATTAAAGATATGCAGCGCAACTGGATCGGCCGTTCGGAAGGCGCTCACGTTCATTTTGCTATAGATGGACATGATGATTCCTTTACAGTGTTTACAACAG Youngman (35) . Plasmid pVH401, which later proved to contain part of the leuS+ gene, was used as a probe to isolate bacteriophage lambda clones from DNA libraries constructed from B. subtilis leuS+ or leuSl-containing DNA.
The analysis below describes how the clones were tested.
Endpoint analysis. Clones containing DNA from the leuSI region were tested for their ability to replace the leuS+ allele in transformed cells (Fig. 3) . One microgram of DNA to be tested for the presence of leuSi was mixed with 0.1 ,ug of chromosomal DNA isolated from CU3989 (leuS+ ilvN::Tn917[60]). The mixture was then used to transform CU1065 (leuS+ ilvN+) with selection for Camr on TBAB containing X-Gal. All transformants carry an ilvN::lacZ transcriptional fusion. Blue transformants (leuSl congressants) occurred at a rate higher than 10-2 when X-leuSJ or pVH402 DNA was cotransformed with the selected DNA. Blue transformants were never observed (rate, <10-4) when plasmid pVH404 was added to the selectable DNA. When experimental DNA was omitted or leuS+-derived DNA clones were added to the transformation, blue colonies occurred at a rate lower than 10-5. The results of this experiment placed the leuSI mutation between the endpoints of the chromosomal DNA in plasmids pVH402 and pVH404.
The reverse experiment (replacing the leuSI allele with leuS+) was conducted and confirmed that leuS+ is located between the restriction sites of plasmids pVH401 and pVH403. A leuSl-to-leuS+ revertant was never seen in these experiments, indicating that the leuSl mutation reverts at a frequency lower than 105.
Analysis of the B. subtilis leuS nucleotide sequence. The DNA sequence was determined for the leuSJ-containing junction fragments (Fig. 4) . This region was found to contain an open reading frame that extends from the EcoRI site of pVH401 through the HindIII site and toward the transposon. Comparison of the DNA sequences cloned from plasmids pVH401 (leuS+) and pVH402 (leuSI) identified a singlebase-pair difference. An A in the open reading frame (nucleotide 2084) derived from pVH401 DNA is a G in pVH402-derived DNA. This substitution results in the amino acid glutamate being replaced by a lysine residue in the mutant polypeptide.
Inspection of DNA sequences flanking this region revealed a possible ribosomal binding site (21, 29) immediately upstream of the 5' end of the open reading frame. Use of UUG as a start codon has been observed a number of times in B. subtilis (28) . On the 3-flanking region we identified the
end of the open reading frame. A possible transcriptional terminator was identified shortly after the presumptive stop codon.
We identified a fairly good consensus sequence for a vegetative promoter 206 bases upstream of the start codon (21) . The -35 region (beginning at base 156 in Fig. 4) is a four-of-six match with the consensus sequence (TTGACA). A 17-bp spacer is followed by a -10 region that matches four of six bases with the consensus sequence (TATAAT). Two inverted repeats were identified between the possible promoter and the predicted start of the open reading frame. The second repeat would be expected to function as a transcriptional terminator. Just upstream of this presumptive terminator we identified a T box. A T box is a sequence found upstream of leader-mRNA terminators of Bacillus tRNA synthetase genes and of the B. subtilis ilv-leu operon (14) . The role of the T box has yet to be identified.
The DNA sequence of the open reading frame was compared with sequences in the GenBank and EMBL data bases by using the program FASTA (23 an intact gene made demonstration of leucyl-tRNA synthetase activity, either enzymically or by complementation, very difficult. Although we think that these barriers can be overcome, the evidence is strong that we have cloned the leuS gene of B. subtilis.
The best evidence is the striking homology between the B. subtilis leuS and the leucyl-tRNA synthetases of other species. There is also cross-regulation of the ilv-leu operon, the signature T box, and the fact that leuSi mutants grow slowly. Slow growth cannot be attributed to overexpression of the ilv-leu operon, since it was observed in several Ilvand Leu-auxotrophs. Before the homology with the E. coli leucyl-tRNA synthetase was identified, we made several attempts to inactivate the gene by allele replacement with a Tn5::cat-mutagenized plasmid clone (data not shown). The failure of these experiments suggests that letiS is essential and is present in a single copy.
The B. subtilis leucyl-tRNA synthetase contains all of the consensus sequences relevant to known structural features and functional domains present in XUX and other type I tRNA synthetases (3, 18, 25) . A large gap in the B. subtilis enzyme sequence (or an insertion in the E. coli enzyme sequence) has an endpoint immediately upstream of the KMSKS box, which is part of the nucleotide binding site.
The leuS] mutation itself alters the residue just upstream of this conserved motif.
It is not surprising that a mutation in the leuS gene affects expression of the ilv-leu operon. The biosynthetic operon may be regulated by transcriptional attenuation (11) . Analogous mutations affecting amino acid biosynthetic operons of E. coli were instrumental in learning the mechanism of attenuation (for a review, see reference 16) .
Alternatively, the leuS gene may influence the ilv-leu operon by molecular mimicry. According to this model of regulation, first suggested by Ames et al. (1), synthetases and tRNA-modifying proteins bind to mRNA sequences that are homologous to their tRNA substrates. For example, the thrS operon of E. coli is autoregulated at the level of translation by the binding of threonyl-tRNA synthetase to its own mRNA (20) at two sites. At least one of these sites is believed to overlap the thrS ribosomal binding site and to prevent translational initiation. Scanning of the leuS and ilv-leu operon leaders for tRNALCU sequences (data not shown) suggests that both contain regions homologous to the tRNALeU D loop. Such homology was identified twice in the ilv-leu operon leader (30) and twice in the leuS mRNA.
In leuS, this method of regulation deserves special attention. No leader peptide sequence could be detected based upon the sequencing data. There are two regions of tRNALeU homology. In the first, leuS nucleotides 223 through 241 (Fig.  4) share 13 of 19 identical bases with nucleotides 10 through 27 (the D loop) of leucyl-tRNACAG. This sequence appears in leuS at the upstream base and stem of the terminator in the leader mRNA, overlapping and between the T box and the terminator. The second site of homology is between nucleotides 390 and 402 of leuS and nucleotides 14 and 25 of leucyl-tRNACAG. Eleven of the 12 bases are identical between these sequences. Although the D loop of tRNALeu is conserved in evolution and interacts tightly with leucyltRNA synthetase (7), more evidence is required before we can say that LeuS is a trans-acting regulatory element for the leuS and ilv-leu operons. That study should include an examination of the role of T boxes.
